Alkergot en es it fr

Alkergot Brand names, Alkergot Analogs

Alkergot Brand Names Mixture

  • No information avaliable

Alkergot Chemical_Formula


Alkergot RX_link

No information avaliable

Alkergot fda sheet

Alkergot msds (material safety sheet)

Alkergot Synthesis Reference

No information avaliable

Alkergot Molecular Weight

591.741 g/mol

Alkergot Melting Point

No information avaliable

Alkergot H2O Solubility

No information avaliable

Alkergot State


Alkergot LogP


Alkergot Dosage Forms

Capsule; Liquid; Powder; Powder for solution; Solution; Syrup; Tablet

Alkergot Indication

For use as an adjunct therapy for patients with dementia

Alkergot Pharmacology

Ergoloid Mesylate may increase cerebral metabolism and blood flow. The role of this medication in the therapy of dementia is controversial. A recent controlled study in patients with Alzheimer's disease found that there was no advantage to the use of ergoloid mesylates compared to placebo, suggesting that ergoloid mesylates may lower scores on some cognitive and behavioral rating scales. Further study is needed to determine the risk-benefit profile of ergoloid mesylates in the treatment of dementia.

Alkergot Absorption

Rapidly but incompletely (approximately 25%) absorbed from the gastrointestinal tract. Approximately 50% of the absorbed dose is eliminated by first-pass metabolism.

Alkergot side effects and Toxicity

Symptoms of overdose include dyspnea, hypotension or hypertension, rapid weak pulse, delirium, nausea, vomiting, and bradycardia.

Alkergot Patient Information

No information avaliable

Alkergot Organisms Affected

Humans and other mammals